Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Semaglutide has a long track record and is often a starting point
4.6% in the non-GLP-1 group Significantly lower rates of acute myocardial infarction Lower risk of major adverse cardiac events overall Psoriatic arthritis already raises cardiovascular risk substantially
On a standard 3mL dial-a-dose pen, one click equals 0.01mL
Insufficient weight loss The STEP trials produced their impressive results at 2.4 mg
US$ 24.20
US$ 22.14
US$ 20.21
US$ 23.83
